scispace - formally typeset
A

Ananda Mukherjee

Researcher at Jadavpur University

Publications -  32
Citations -  620

Ananda Mukherjee is an academic researcher from Jadavpur University. The author has contributed to research in topics: PTEN & Histone. The author has an hindex of 11, co-authored 30 publications receiving 522 citations. Previous affiliations of Ananda Mukherjee include Michigan State University & Rajiv Gandhi Centre for Biotechnology.

Papers
More filters
Journal ArticleDOI

In Vitro Structural and Functional Evaluation of Gold Nanoparticles Conjugated Antibiotics

TL;DR: The findings indicated that Gnps conjugated antibiotics are more efficient and might have significant therapeutic implications.
Journal ArticleDOI

Interplay between autophagy and apoptosis mediated by copper oxide nanoparticles in human breast cancer cells MCF7

TL;DR: This study indicates that CuO NPs are a potent inducer of autophagy which may be a cellular defense against the CuO NP mediated toxicity and inhibition of Autophagy switches the cellular response into apoptosis.
Journal ArticleDOI

Gold Nanoparticles Conjugated Antibiotics: Stability and Functional Evaluation

TL;DR: Gold nanoparticles co-synthesized with antibiotics showed greater bactericidal activity and reduced minimal inhibitory concentration compared to their respective free forms, indicating that Gnps conjugated antibiotics are more efficient and may have significant therapeutic implications in the near future.
Journal ArticleDOI

Antibacterial activities of polyethylene glycol, tween 80 and sodium dodecyl sulphate coated silver nanoparticles in normal and multi-drug resistant bacteria.

TL;DR: Polyethylene glycol coated nanoparticles were most effective in killing all the bacterial strains which includes Escherichia coli DH5a, Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus and multi-drug resistant clinical isolates of Shigella spp.
Journal ArticleDOI

Enhanced expression of histone chaperone APLF associate with breast cancer.

TL;DR: Novel evidence is provided for enrichment of APLF in breast tumors, which could regulate metastasis-associated EMT in invasive breast cancer and be exploited as a biomarker for breast tumors and additionally could be targeted in sensitizing cancer cells towards DNA damaging agents.